Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: An epidemiologic model-based study

Transfusion

Volumn 52, Issue 6, 2012, Pages 1290-1295

  Pillonel, Josiane ^a,b,c,d   Brandel, Jean Philippe ^a,b,c,d   Léon, Lucie ^a,b,c,d   Salomon, Dominique ^a,b,c,d   Haïk, Stéphane ^a,b,c,d   Capek, Isabelle ^a,b,c,d   Vaillant, Véronique ^a,b,c,d   Coste, Joliette ^a,b,c,d   Alpérovitch, Annick ^a,b,c,d  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b CNRS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FEMALE; FRANCE; GENDER; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MORTALITY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; ASYMPTOMATIC DISEASES; BLOOD DONORS; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; EPIDEMIOLOGIC STUDIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; RISK; YOUNG ADULT;

EID: 84862249081     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03459.x     Document Type: Article

References (21)

1. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alpérovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
2. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21. (Pubitemid 38210057)
3. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9. (Pubitemid 39070413)
4. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Lineham JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368: 2061-7. (Pubitemid 44855106)
5. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study. Vox Sang 2006;91:221-30. (Pubitemid 44337279)
6. Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-84: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113-9.
7. Wientjens DP, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, van Duijn CM. Risk factors for Creuzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 1996;46:1287-91. (Pubitemid 26159288)
8. van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, Zerr I, de Silva R, Wientjens DP, Brandel JP, Weber T, Bonavita V, Zeidler M, Alperovitch A, Poser S, Granieri E, Hofman A, Will RG; for the European Union Collaborative Study Group of Creutzfeldt-Jakob disease. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998;351:1081-5. (Pubitemid 28162198)
9. Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie N, Will R, Poser S. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000;53:747-54. (Pubitemid 30609629)
10. Puopolo M, Ladogana A, Vetrugno V, Pocchiari M. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor and possible biases. Transfusion 2011;51:1556-66.
11. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based bioassay. Lancet 2011;377: 487-93.
12. Alpérovitch A, Delasnerie-Laupêtre N, Brandel JP, Salomon D. La maladie de Creutzfeldt-Jakob en France, 1992-2002. Institut de Veille Sanitaire, Saint-Maurice, France 2004 ISBN: 2-11-094961-9. [cited 2011 Sep 26]. Available from: URL: http://www.invs.sante.fr/publications/2004/mcj-1992-2002/ index.html
13. Alpérovitch A, Zerr I, Pocchiari M, Mitrova E, Cuesta J, Hegyi I, Collins S, Kretzschmar H, van Duijn C, Will RG. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999;353:1673-4. (Pubitemid 29224526)
14. Pillonel J, Laperche S, Saura C, Desenclos JC, CouroucéAM; the Transfusion-Transmissible AgentsWorking Group of the French Society of Blood Transfusion. Trends in residual risk of transfusion transmitted viral infections in France between 1992 and 2000. Transfusion 2002;42:980-8.
15. Brown P. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 2007;13 Suppl 5: 33-40. (Pubitemid 350253402)
16. Brown P, Gibbs J, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-29. (Pubitemid 24153834)
17. Manuelidis EE, Gorgacz EJ, Manuelidis L. Viremia in experimental Creutzfeldt-Jakob disease. Science 1978;200: 1069-71. (Pubitemid 8346929)
18. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-7. (Pubitemid 29103801)
19. Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie- Lauprêtre N, Zerr I, Poser S, van Duijn CM. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002; 59:543-8. (Pubitemid 34919987)
20. de Pedro-Cuesta J, Mahillo-Fernández I, Rábano A, Calero M, Cruz M, Siden A, Laursen H, Falkenhorst G, Mølbak K; EUROSURGYCJD Research Group. Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry 2011;82:204-12.
21. Walllis JP, Wells AW, Matthews JN, Chapman CE. Long-term survival after blood transfusion: a population-based study in the North of England. Transfusion 2004;44:1025-32. (Pubitemid 38823809)